Last 28.30 INR
Change Today -0.70 / -2.41%
Volume 224.6K
NLSC On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

nectar lifesciences ltd (NLSC) Snapshot

Open
29.15
Previous Close
29.00
Day High
29.50
Day Low
28.10
52 Week High
06/9/14 - 35.00
52 Week Low
08/6/13 - 9.65
Market Cap
6.3B
Average Volume 10 Days
273.3K
EPS TTM
2.77
Shares Outstanding
224.3M
EX-Date
--
P/E TM
10.2x
Dividend
0.10
Dividend Yield
0.35%
Current Stock Chart for NECTAR LIFESCIENCES LTD (NLSC)

Related News

No related news articles were found.

nectar lifesciences ltd (NLSC) Related Businessweek News

No Related Businessweek News Found

nectar lifesciences ltd (NLSC) Details

Nectar Lifesciences Limited, an integrated pharmaceutical company, primarily manufactures various active pharmaceutical ingredients (APIs) and intermediates, and finished dosage forms in India and internationally. The company’s contract research and manufacturing services include process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, pilot plant production, bulk production, and Chiral resolution; and chemical and analytical development, and analytical and manufacturing services, as well as engineering consulting services. Its APIs and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, buffered and unbuffered cefepime HCL, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspension, and granules and injectibles. In addition, it provides generic and OTC products for various therapeutic areas; a range of in-vitro diagnostics products; empty hard gelatin capsules; and manufactures menthol and allied products, such as menthol crystals, menthol flakes, peppermint oil, cis 3 hexenol, mentha piperita, Indian spearmint oil, menthones, mint blends, dementholised peppermint oil, and other customized mint based products. The company was founded in 1995 and is headquartered in New Delhi, India.

Founded in 1995

nectar lifesciences ltd (NLSC) Top Compensated Officers

Chairman, Managing Director, Member of Audit ...
Total Annual Compensation: 7.3M
Chief Executive Officer and Wholetime Directo...
Total Annual Compensation: 4.3M
President of Operations and Wholetime Directo...
Total Annual Compensation: 901.7K
Executive Director and Member of Share Transf...
Total Annual Compensation: 7.2M
Compensation as of Fiscal Year 2013.

nectar lifesciences ltd (NLSC) Key Developments

New Silk And Other Reportedly To Sell Stake In Nectar

New Silk Route and Sanjiv Goyal and family is reportedly looking to sell their stake in Nectar Lifesciences Limited (BSE:532649). IDFC has been reportedly hired to look for buyers.

NSR To Sell Stake In Nectar

New Silk Route (NSR) and Sanjiv Goyal and family is to sell their stake in Nectar Lifesciences Limited (BSE:532649), three people with knowledge of the development said. IDFC has been given a sell side mandate to scout for potential strategic investors/buyers. The envisaged sale involves 44.3% stake held by promoters, Sanjiv Goyal and Family and 11.59% stake of NSR.

Nectar Lifesciences Limited Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2014

Nectar Lifesciences Limited reported audited consolidated earnings results for the year ended March 31, 2014. For the period, the company’s net sales were INR 16,377.692 million compared to INR 16,248.143 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 2,045.826 million compared to INR 2,141.240 million a year ago. Profit from ordinary activities before tax was INR 782.227 million compared to INR 1,146.750 million a year ago. Net profit was INR 620.799 million or INR 2.77 per basic and diluted share before and after extraordinary items compared to INR 856.655 million or INR 3.82 per basic and diluted share before and after extraordinary items for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NLSC:IN 28.30 INR -0.70

NLSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NLSC.
View Industry Companies
 

Industry Analysis

NLSC

Industry Average

Valuation NLSC Industry Range
Price/Earnings 8.9x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 3.8x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NECTAR LIFESCIENCES LTD, please visit www.neclife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.